With the debut of Ellage at International Seminar 2020, PCCA has introduced a revolutionary anhydrous vaginal base. Here are just a few of the exciting reasons why Ellage should be your pharmacy's go-to base when it comes to vaginal applications.

Mark Gonzalez, PharmD, is a clinical compounding pharmacist at PCCA. He has five exciting and practical tips that can help a pharmacy end the year stronger than they began.

Congratulations to Adrianna Rodriguez, CPhT, a pharmacy technician at Stone Oak Pharmacy in San Antonio, Texas for being our November Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.

Maria Carvalho briefly discusses and provides 8 of the published, peer-reviewed stability studies of compounded medications with PCCA's SuspendIt. These studies were conducted by the researchers at Xavier University of Louisiana.

PCCA's Formula Development team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a key component of PCCA's abiding desire to provide pharmacies with formulas that alleviate patient health challenges. The Formula Development Spotlight is a limited series of articles designed to highlight a singular member of the Formula Development team. This article focuses on Stacey Lemus.

PCCA's Marketing Manager Sarah DeCarlo provides a cutting-edge list of exciting ways pharmacists and pharmacy owners can use the Shop Small® movement to market their pharmacies.

Congratulations to Your Discount Chemist Port Macquarie in Port Macquarie, New South Wales, Australia for being our October Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of pharmacy compounding by providing the highest quality of service to their patients.

Bill Letendre, PCCA's Vice President of Pharmacy Management Systems (CPMS) discusses how building partnerships with other surrounding businesses in communities can be a powerful marketing tool for compounding pharmacies.

Members of PCCA's Clinical Services and PCCA Science teams provide a review of some of the research into the morbidity, mortality and pathogenicity of SARS-CoV-2. The information gathered is based on the best scientific evidence currently available regarding potential treatments. They also take the time to explore some potential non-prescription and prescription options based on their research.

Gus Bassani, PCCA's Chief Scientific Officer, discusses the important nuances compounders should know when dealing with brand name products versus their generic counterparts and FDA's position on buying from quality raw material providers.